Frontiers in VirologyMolecular BiologyPeer-reviewed journal article
Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions
Abstract
The genome of the SARS-CoV-2 Omicron variant (B.1.1.529) was released on November 22, 2021, which has caused a flurry of media attention due the large number of mutations it contains. These raw data have spurred questions around vaccine efficacy. Given that neither the structural information nor the experimentally-derived antibody interaction of this variant are available, we have turned to predictive computational methods to model the mutated structure of the spike proteins receptor binding domain and posit potential changes to vaccine efficacy. In this study, we predict some structural changes in the receptor-binding domain that may reduce antibody interaction without completely evading existing neutralizing antibodies (and therefore current vaccines).
- organism: virus
- assay: protein structure
- research focus: protein structure prediction
- approach: statistical model
- Citations
- 52
- FWCI
- 5.88
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The influence of new SARS-CoV-2 variant Omicron (B.1.1.529) on vaccine efficacy, its correlation to Delta Variants: a computational approach
Prashant Ranjan, Neha Neha, … Parimal Kumar Das·Microbial PathogenesisPeer-reviewed·Jan 1, 2022
- Structural basis of Omicron immune evasion: A comparative computational study of Spike protein-Antibody interaction.
D. Contractor, C. Globisch, … A. Jain·bioRxiv·Mar 15, 2022
- Structural basis for antibody resistance to SARS-CoV-2 omicron variant
G. Cerutti, Y. Guo, … L. Shapiro·bioRxiv·Dec 21, 2021
- Structural insight into antibody evasion of SARS-CoV-2 omicron variant
Jyoti Kumar Verma, Naidu Subbarao·bioRxiv·Jan 25, 2022
- Structural insights for neutralization of BA.1 and BA.2 Omicron variants by a broadly neutralizing SARS-CoV-2 antibody
S. Kumar, A. Patel, … A. Chandele·bioRxiv·May 13, 2022
- SARS-CoV-2 vaccine-breakthrough infections (VBIs) by Omicron (B.1.1.529) variant and consequences in structural and functional impact
Zainularifeen Abduljaleel, Sami Melebari, … C. George Priya Doss·Cellular SignallingPeer-reviewed·Jul 7, 2023